224 related articles for article (PubMed ID: 25852011)
21. Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging.
Yi CA; Shin KM; Lee KS; Kim BT; Kim H; Kwon OJ; Choi JY; Chung MJ
Radiology; 2008 Aug; 248(2):632-42. PubMed ID: 18552311
[TBL] [Abstract][Full Text] [Related]
22. Non-small cell lung cancer: whole-body MR examination for M-stage assessment--utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT.
Ohno Y; Koyama H; Onishi Y; Takenaka D; Nogami M; Yoshikawa T; Matsumoto S; Kotani Y; Sugimura K
Radiology; 2008 Aug; 248(2):643-54. PubMed ID: 18539889
[TBL] [Abstract][Full Text] [Related]
23. TNM Staging of Non-Small Cell Lung Cancer: Comparison of PET/MR and PET/CT.
Huellner MW; de Galiza Barbosa F; Husmann L; Pietsch CM; Mader CE; Burger IA; Stolzmann P; Delso G; Frauenfelder T; von Schulthess GK; Veit-Haibach P
J Nucl Med; 2016 Jan; 57(1):21-6. PubMed ID: 26471696
[TBL] [Abstract][Full Text] [Related]
24. Diagnostic value of fluorine 18 fluorodeoxyglucose positron emission tomography/computed tomography for the detection of metastases in non-small-cell lung cancer patients.
Wu Y; Li P; Zhang H; Shi Y; Wu H; Zhang J; Qian Y; Li C; Yang J
Int J Cancer; 2013 Jan; 132(2):E37-47. PubMed ID: 22890912
[TBL] [Abstract][Full Text] [Related]
25. Prospective comparison of
Kirchner J; Sawicki LM; Nensa F; Schaarschmidt BM; Reis H; Ingenwerth M; Bogner S; Aigner C; Buchbender C; Umutlu L; Antoch G; Herrmann K; Heusch P
Eur J Nucl Med Mol Imaging; 2019 Feb; 46(2):437-445. PubMed ID: 30074073
[TBL] [Abstract][Full Text] [Related]
26. Value of positron emission tomography for lung cancer staging.
Albes JM; Dohmen BM; Schott U; Schülen E; Wehrmann M; Ziemer G
Eur J Surg Oncol; 2002 Feb; 28(1):55-62. PubMed ID: 11869015
[TBL] [Abstract][Full Text] [Related]
27. Clinical Performance of Whole-Body 18F-FDG PET/Dixon-VIBE, T1-Weighted, and T2-Weighted MRI Protocol in Colorectal Cancer.
Lee SJ; Seo HJ; Kang KW; Jeong SY; Yi NJ; Lee JM; Chung JK; Edmund Kim E; Paeng JC; Cheon GJ; Lee DS
Clin Nucl Med; 2015 Aug; 40(8):e392-8. PubMed ID: 26018689
[TBL] [Abstract][Full Text] [Related]
28. Fast T1- and T2-weighted pulmonary MR-imaging in patients with bronchial carcinoma.
Both M; Schultze J; Reuter M; Bewig B; Hubner R; Bobis I; Noth R; Heller M; Biederer J
Eur J Radiol; 2005 Mar; 53(3):478-88. PubMed ID: 15741023
[TBL] [Abstract][Full Text] [Related]
29. Comparison of MRI Sequences in Whole-Body PET/MRI for Staging of Patients With High-Risk Prostate Cancer.
Metser U; Chan R; Veit-Haibach P; Ghai S; Tau N
AJR Am J Roentgenol; 2019 Feb; 212(2):377-381. PubMed ID: 30332285
[TBL] [Abstract][Full Text] [Related]
30. Initial experience of integrated PET/MR mammography in patients with invasive ductal carcinoma.
Kong EJ; Chun KA; Bom HS; Lee J; Lee SJ; Cho IH
Hell J Nucl Med; 2014; 17(3):171-6. PubMed ID: 25397622
[TBL] [Abstract][Full Text] [Related]
31. [Value of (18)F-FDG PET-CT in the preoperative N staging of non-small cell lung cancer].
Li M; Wu N; Liang Y; Zheng R; Liu Y; Zhang WJ; Zhao P
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):288-92. PubMed ID: 19615286
[TBL] [Abstract][Full Text] [Related]
32. Progressing Toward a Cohesive Pediatric 18F-FDG PET/MR Protocol: Is Administration of Gadolinium Chelates Necessary?
Klenk C; Gawande R; Tran VT; Leung JT; Chi K; Owen D; Luna-Fineman S; Sakamoto KM; McMillan A; Quon A; Daldrup-Link HE
J Nucl Med; 2016 Jan; 57(1):70-7. PubMed ID: 26471690
[TBL] [Abstract][Full Text] [Related]
33. Mediastinal lymph nodes staging by 18F-FDG PET/CT for early stage non-small cell lung cancer: a multicenter study.
Li X; Zhang H; Xing L; Ma H; Xie P; Zhang L; Xu X; Yue J; Sun X; Hu X; Chen M; Xu W; Chen L; Yu J
Radiother Oncol; 2012 Feb; 102(2):246-50. PubMed ID: 22100657
[TBL] [Abstract][Full Text] [Related]
34. Pulmonary Nodule Detection in Patients with a Primary Malignancy Using Hybrid PET/MRI: Is There Value in Adding Contrast-Enhanced MR Imaging?
Lee KH; Park CM; Lee SM; Lee JM; Cho JY; Paeng JC; Ahn SY; Goo JM
PLoS One; 2015; 10(6):e0129660. PubMed ID: 26065695
[TBL] [Abstract][Full Text] [Related]
35. Stage T1 non-small cell lung cancer: preoperative mediastinal nodal staging with integrated FDG PET/CT--a prospective study.
Kim BT; Lee KS; Shim SS; Choi JY; Kwon OJ; Kim H; Shim YM; Kim J; Kim S
Radiology; 2006 Nov; 241(2):501-9. PubMed ID: 16966480
[TBL] [Abstract][Full Text] [Related]
36. Improved non-invasive T-Staging in non-small cell lung cancer by integrated 18F-FDG PET/CT.
Pauls S; Buck AK; Hohl K; Halter G; Hetzel M; Blumstein NM; Mottaghy FM; Glatting G; Krüger S; Sunder-Plassmann L; Möller P; Hombach V; Brambs HJ; Reske SN
Nuklearmedizin; 2007; 46(1):9-14; quiz N1-2. PubMed ID: 17299649
[TBL] [Abstract][Full Text] [Related]
37. Clinical application of 3D VIBECAIPI-DIXON for non-enhanced imaging of the pancreas compared to a standard 2D fat-saturated FLASH.
Haneder S; Koziel K; Morelli JN; Riffel P; Budjan J; Schoenberg SO; Michaely HJ
Clin Imaging; 2014; 38(2):142-7. PubMed ID: 24332974
[TBL] [Abstract][Full Text] [Related]
38. Impact of point spread function reconstruction on thoracic lymph node staging with 18F-FDG PET/CT in non-small cell lung cancer.
Lasnon C; Hicks RJ; Beauregard JM; Milner A; Paciencia M; Guizard AV; Bardet S; Gervais R; Lemoel G; Zalcman G; Aide N
Clin Nucl Med; 2012 Oct; 37(10):971-6. PubMed ID: 22899197
[TBL] [Abstract][Full Text] [Related]
39. Quantitative modifications of TNM staging, clinical staging and therapeutic intent by FDG-PET/CT in patients with non small cell lung cancer scheduled for radiotherapy--a retrospective study.
Abramyuk A; Appold S; Zöphel K; Hietschold V; Baumann M; Abolmaali N
Lung Cancer; 2012 Nov; 78(2):148-52. PubMed ID: 22922126
[TBL] [Abstract][Full Text] [Related]
40. Detection and size of pulmonary lesions: how accurate is MRI? A prospective comparison of CT and MRI.
Heye T; Ley S; Heussel CP; Dienemann H; Kauczor HU; Hosch W; Libicher M
Acta Radiol; 2012 Mar; 53(2):153-60. PubMed ID: 22287146
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
